A neurologist writing for the UK tabloid press argues that new Alzheimer’s drugs do not provide the kind of protection many people expect, and that health efforts should focus more on prevention. The article uses an analogy comparing treating only symptoms to firefighting that targets smoke rather than flames.
The piece presents the clinician’s view that current drug strategies have limitations and should not be relied on as a definitive “save your brain” solution. It also calls for changes to daily habits, positioning these steps as potentially more impactful for reducing risk. The reporting centers on the neurologist’s perspective rather than new clinical data, and it does not present detailed evidence or results from specific trials in the supplied text.
Across the provided sources, the framing is consistent: both outlets publish essentially the same article with the same critic of drug efficacy and the same emphasis on preventive lifestyle measures.
